BackSmith & Nephew plc Overview
Smith & Nephew plc - ADR

Smith & Nephew plc Target Price

Analysts' average 12-month price target for Smith & Nephew plc is $34.

Get informed when a big investor buys or sells

+ Follow

Share Price

$26.42

Average Target Price

$33.8828.2% upside

1 analysts in the last 4 months

High: $33.88 | Low: $33.88

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-11Berenberg Bank$33.8828.2% upsideOpen
2026-05-11Bernstein$31.8520.6% upsideOpen
2026-05-11Canaccord Genuity$3013.6% upsideOpen
2026-04-24Canaccord GenuityCaitlin Cronin$3221.1% upsideOpen
2025-10-14Bernstein$37.541.9% upsideOpen
2025-08-18Canaccord GenuityCaitlin Cronin$3636.3% upsideOpen
2024-11-04Canaccord GenuityKyle Rose$272.2% upsideOpen

Smith & Nephew plc (SNN) FAQ

The latest target price for SNN is $34. Investors often review this figure alongside Smith & Nephew plc's historical trend and sector peers before judging valuation or financial health.

Smith & Nephew plc trades near $26.42 while the consensus target sits at $34 (28.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting SNN's target price ($34), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Smith & Nephew plc's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.